EUVIMEDEUVIMED entdecken
KorrekturOpen Access

Erratum to “BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma”

Xiao-Peng Tian, Jun Cai, Shu-Yun Ma, Yu Fang, Hui-Qiang Huang, Tong-Yu Lin, Hui-Lan Rao, Mei Li, Zhong-Jun Xia, Tie-Bang Kang, Dan Xie, Qing-Qing Cai

Cancer Communications · 01.01.2026 · 46

DOI: 10.34133/cancomm.0061 ↗

Kurz gefasst

Korrektur in der Zeitschrift Cancer Communications, online erschienen am 03.11.2026. Verfasst von Xiao-Peng Tian und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou…. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China.
  • Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China.
  • Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China.
  • Department of Hematology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China.

Zitieren

APA

Tian, X. P., Cai, J., Ma, S. Y., Fang, Y., Huang, H. Q., Lin, T. Y., Rao, H. L., Li, M., Xia, Z. J., Kang, T. B., Xie, D., & Cai, Q. Q. (2026). Erratum to “BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma”. Cancer Communications, 46. https://doi.org/10.34133/cancomm.0061

Vancouver

Tian XP, Cai J, Ma SY, Fang Y, Huang HQ, Lin TY, et al. Erratum to “BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma”. Cancer Communications. 2026;46. doi:10.34133/cancomm.0061

BibTeX
@article{Tian2026,
  author = {Tian, Xiao-Peng and Cai, Jun and Ma, Shu-Yun and Fang, Yu and Huang, Hui-Qiang and Lin, Tong-Yu and Rao, Hui-Lan and Li, Mei and Xia, Zhong-Jun and Kang, Tie-Bang and Xie, Dan and Cai, Qing-Qing},
  title = {Erratum to “BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma”},
  journal = {Cancer Communications},
  year = {2026},
  volume = {46},
  doi = {10.34133/cancomm.0061}
}
Kostenlos starten →